Global Female Contraception Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Female Contraception Drug

• 1.1 Definition of Female Contraception Drug
• 1.2 Female Contraception Drug Segment by Type
  • 1.2.1 Global Female Contraception Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 AG-890
  • 1.2.3 Amphora
  • 1.2.4 BAY-1007626
  • 1.2.5 Drospirenone
  • 1.2.6 Others
• 1.3 Female Contraception Drug Segment by Applications
  • 1.3.1 Global Female Contraception Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Homecare
• 1.4 Global Female Contraception Drug Overall Market
  • 1.4.1 Global Female Contraception Drug Revenue (2014-2025)
  • 1.4.2 Global Female Contraception Drug Production (2014-2025)
  • 1.4.3 North America Female Contraception Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Female Contraception Drug Status and Prospect (2014-2025)
  • 1.4.5 China Female Contraception Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Female Contraception Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Female Contraception Drug Status and Prospect (2014-2025)
  • 1.4.8 India Female Contraception Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Female Contraception Drug
• 2.3 Manufacturing Process Analysis of Female Contraception Drug
• 2.4 Industry Chain Structure of Female Contraception Drug

3 Development and Manufacturing Plants Analysis of Female Contraception Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Female Contraception Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Female Contraception Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Female Contraception Drug Production and Capacity Analysis
• 4.2 Female Contraception Drug Revenue Analysis
• 4.3 Female Contraception Drug Price Analysis
• 4.4 Market Concentration Degree

5 Female Contraception Drug Regional Market Analysis

• 5.1 Female Contraception Drug Production by Regions
  • 5.1.1 Global Female Contraception Drug Production by Regions
  • 5.1.2 Global Female Contraception Drug Revenue by Regions
• 5.2 Female Contraception Drug Consumption by Regions
• 5.3 North America Female Contraception Drug Market Analysis
  • 5.3.1 North America Female Contraception Drug Production
  • 5.3.2 North America Female Contraception Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Female Contraception Drug Import and Export
• 5.4 Europe Female Contraception Drug Market Analysis
  • 5.4.1 Europe Female Contraception Drug Production
  • 5.4.2 Europe Female Contraception Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Female Contraception Drug Import and Export
• 5.5 China Female Contraception Drug Market Analysis
  • 5.5.1 China Female Contraception Drug Production
  • 5.5.2 China Female Contraception Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Female Contraception Drug Import and Export
• 5.6 Japan Female Contraception Drug Market Analysis
  • 5.6.1 Japan Female Contraception Drug Production
  • 5.6.2 Japan Female Contraception Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Female Contraception Drug Import and Export
• 5.7 Southeast Asia Female Contraception Drug Market Analysis
  • 5.7.1 Southeast Asia Female Contraception Drug Production
  • 5.7.2 Southeast Asia Female Contraception Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Female Contraception Drug Import and Export
• 5.8 India Female Contraception Drug Market Analysis
  • 5.8.1 India Female Contraception Drug Production
  • 5.8.2 India Female Contraception Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Female Contraception Drug Import and Export

6 Female Contraception Drug Segment Market Analysis (by Type)

• 6.1 Global Female Contraception Drug Production by Type
• 6.2 Global Female Contraception Drug Revenue by Type
• 6.3 Female Contraception Drug Price by Type

7 Female Contraception Drug Segment Market Analysis (by Application)

• 7.1 Global Female Contraception Drug Consumption by Application
• 7.2 Global Female Contraception Drug Consumption Market Share by Application (2014-2019)

8 Female Contraception Drug Major Manufacturers Analysis

• 8.1 Addex Therapeutics Ltd
  • 8.1.1 Addex Therapeutics Ltd Female Contraception Drug Production Sites and Area Served
  • 8.1.2 Addex Therapeutics Ltd Product Introduction, Application and Specification
  • 8.1.3 Addex Therapeutics Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Agile Therapeutics Inc
  • 8.2.1 Agile Therapeutics Inc Female Contraception Drug Production Sites and Area Served
  • 8.2.2 Agile Therapeutics Inc Product Introduction, Application and Specification
  • 8.2.3 Agile Therapeutics Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bayer AG
  • 8.3.1 Bayer AG Female Contraception Drug Production Sites and Area Served
  • 8.3.2 Bayer AG Product Introduction, Application and Specification
  • 8.3.3 Bayer AG Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Evofem Inc
  • 8.4.1 Evofem Inc Female Contraception Drug Production Sites and Area Served
  • 8.4.2 Evofem Inc Product Introduction, Application and Specification
  • 8.4.3 Evofem Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Hervana Ltd
  • 8.5.1 Hervana Ltd Female Contraception Drug Production Sites and Area Served
  • 8.5.2 Hervana Ltd Product Introduction, Application and Specification
  • 8.5.3 Hervana Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Mithra Pharmaceuticals SA
  • 8.6.1 Mithra Pharmaceuticals SA Female Contraception Drug Production Sites and Area Served
  • 8.6.2 Mithra Pharmaceuticals SA Product Introduction, Application and Specification
  • 8.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Orbis Biosciences Inc
  • 8.7.1 Orbis Biosciences Inc Female Contraception Drug Production Sites and Area Served
  • 8.7.2 Orbis Biosciences Inc Product Introduction, Application and Specification
  • 8.7.3 Orbis Biosciences Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Teva Pharmaceutical Industries Ltd
  • 8.8.1 Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Sites and Area Served
  • 8.8.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
  • 8.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Viramal Ltd
  • 8.9.1 Viramal Ltd Female Contraception Drug Production Sites and Area Served
  • 8.9.2 Viramal Ltd Product Introduction, Application and Specification
  • 8.9.3 Viramal Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Female Contraception Drug Market

• 9.1 Global Female Contraception Drug Market Trend Analysis
  • 9.1.1 Global Female Contraception Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Female Contraception Drug Regional Market Trend
  • 9.2.1 North America Female Contraception Drug Forecast 2019-2025
  • 9.2.2 Europe Female Contraception Drug Forecast 2019-2025
  • 9.2.3 China Female Contraception Drug Forecast 2019-2025
  • 9.2.4 Japan Female Contraception Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Female Contraception Drug Forecast 2019-2025
  • 9.2.6 India Female Contraception Drug Forecast 2019-2025
• 9.3 Female Contraception Drug Market Trend (Product Type)
• 9.4 Female Contraception Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Female Contraception Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List